Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
12% sodium chondroitin sulfate----1件: 226 💬
240MG triamcinolone injections IN THE bladder----1件: 226 💬
35% lidocaine/5 MG/ML 0.02% estradiol compound cream----1件: 226 💬
4Adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬18件: 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
5AGN 203818----1件: 226 💬
6Alkalinized lidocaine-heparin----1件: 226 💬
7Allorx----8件: 2, 13, 46, 51, 85, 90, 97, 226 💬
8Amitriptyline1件: Amitriptyline2件: Amitriptyline hydrochloride ,
Amitriptyline 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 226, 299 💬
9Amitriptyline/gabapentin1件: Amitriptyline2件: Amitriptyline hydrochloride ,
Amitriptyline 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 226 💬
10AQX-11251件: AQX-1125---1件: 226 💬
11AQX-1125 100 MG1件: AQX-1125---1件: 226 💬
12AQX-1125 200 MG1件: AQX-1125---1件: 226 💬
13ASP3652----1件: 226 💬
14ASP6294----1件: 226 💬
15Atogepant1件: Atogepant1件: Atogepant 💬 1件: CALCRL 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
16Behavioral health consultation/therapy----1件: 226 💬
17Bladder instillation----1件: 226 💬
18Bladder instillation with heparin/ lidocaine----1件: 226 💬
19Bladder instillation with triamcinolone acetonide----1件: 226 💬
20Bladder instillation without triamcinolone acetonide----1件: 226 💬
21Bladder instillations----1件: 226 💬
22Bladder tissue OF interstitial cystitis and normal bladder tissue----1件: 226 💬
23Botox1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬5件: 6, 13, 36, 149, 226 💬
24Botox 100U IN normal saline----1件: 226 💬
25Botox 200U IN normal saline----1件: 226 💬
26Botulinum toxin A1件: Botulinum toxin type A2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 13, 51, 149, 226 💬
27Buckwheat1件: Buckwheat---1件: 226 💬
28Bupivacaine1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 70, 168, 226 💬
29Cannabidiol vaginal suppository1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 226 💬
30Capsaicin1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬4件: 2, 6, 86, 226 💬
31Cascade1件: Flufenoxuron---1件: 226 💬
32Certolizumab pegol1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬7件: 37, 46, 49, 96, 107, 226, 271 💬
33Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬12件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 269 💬
34Ciklosporin----1件: 226 💬
35Clarix FLO----1件: 226 💬
36Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
37Desert harvest aloe vera capsules----1件: 226 💬
38Dexmedetomidine1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
39Dextrose1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--4件: 56, 60, 201, 226 💬
40Dimethyl sulfoxide1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬 --1件: 226 💬
41Dmso1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬 --1件: 226 💬
42Dmso cocktail1件: Dimethyl sulfoxide1件: Dimethyl sulfoxide 💬 --1件: 226 💬
43Eptinezumab1件: Eptinezumab1件: Eptinezumab 💬 1件: CALC 💬 3件: Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
44ERB-041----3件: 46, 96, 226 💬
45Erenumab1件: Erenumab1件: Erenumab 💬 1件: CALCRL 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
46Ferumoxytol1件: Ferumoxytol1件: Ferumoxytol 💬 --2件: 13, 226 💬
47Flavoxate1件: Flavoxate2件: Flavoxate hydrochloride ,
Flavoxate 💬 		16件: PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬 		17件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
48Fospropofol (lusedra®) 101件: Fospropofol1件: Fospropofol disodium 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 226 💬
49Fospropofol (lusedra®) 6.51件: Fospropofol1件: Fospropofol disodium 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 226 💬
50Fremanezumab1件: Fremanezumab1件: Fremanezumab 💬 1件: CALC 💬 3件: Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬2件: 124, 226 💬
51Gadobutrol1件: Gadobutrol1件: Gadobutrol 💬 --4件: 13, 22, 46, 226 💬
52Galcanezumab1件: Galcanezumab1件: Galcanezumab 💬 1件: CALC 💬 3件: Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
53Gefapixant1件: Gefapixant2件: Gefapixant ,
Gefapixant citrate 💬 		1件: P2RX3 💬 4件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬2件: 85, 226 💬
54Glucose1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--9件: 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
55Glycine1件: Glycine1件: Glycine 💬 --6件: 35, 60, 226, 247, 299, 340 💬
56Gralise----2件: 97, 226 💬
57Heparin1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬7件: 47, 60, 65, 70, 84, 107, 226 💬
58Heparin & alkalinized lidocaine bladder instillation1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 226 💬
59High density surface electromyographic, precision botulinum neurotoxin injection guidance medical device----1件: 226 💬
60Hyaluronic acid and chondroitin sulfate1件: Hyaluronic acid2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 226 💬
61Hyaluronic acid/chondroitin sulfate1件: Hyaluronic acid2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 226 💬
62Hydrogen1件: Hydrogen---6件: 5, 6, 17, 97, 226, 288 💬
63Hyperbaric oxygen therapy----3件: 90, 97, 226 💬
64IC cocktail----1件: 226 💬
65Immunonutrition----2件: 96, 226 💬
66Inactive drug----1件: 226 💬
67Injections ON posterior bladder wall excluding THE trigone----1件: 226 💬
68Injections upper aspect OF trigone OF urinary bladder----1件: 226 💬
69Interferential current----1件: 226 💬
70Interferon----1件: 226 💬
71Intermittent exposure TO oxygen VIA ORO-nasal mask----1件: 226 💬
72Intravesical onabotulinumtoxina injection----1件: 226 💬
73Intravesical ozone therapy----1件: 226 💬
74IW-3300 rectal foam----1件: 226 💬
75JNJ-42160443----1件: 226 💬
76Ketorolac tromethamine1件: Ketorolac2件: Ketorolac tromethamine ,
Ketorolac 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 226 💬
77Lidocaine1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬10件: 6, 13, 22, 46, 86, 107, 168, 226, 231, 256 💬
78Liposome encapsulated BONT-A----1件: 226 💬
79Liposomes----1件: 226 💬
80Liris 400 MG----1件: 226 💬
81Liris LOW dose and liris high dose----1件: 226 💬
82Liris® 400 MG----1件: 226 💬
83LOW-dose naltrexone----1件: 226 💬
84LP-08 20MG----1件: 226 💬
85LP-08 80MG----1件: 226 💬
86Methenamine1件: Methenamine3件: Methenamine ,
Methenamine hippurate ,
Methenamine mandelate 💬 		--1件: 226 💬
87Metoprolol tartrate oral tablet1件: Metoprolol4件: Metoprolol tartrate ,
Metoprolol succinate ,
Metoprolol ,
Metoprolol fumarate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
88Mirabegron1件: Mirabegron1件: Mirabegron 💬 1件: ADRB3 💬 9件: Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬4件: 6, 13, 53, 226 💬
89MMF----15件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 84, 107, 222, 224, 226 💬
90MN-001 BID----1件: 226 💬
91MR-MC-01----1件: 226 💬
92Multimodal bundle drugs----1件: 226 💬
93Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
94Naloxone hydrochloride1件: Naloxone3件: Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
95Naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 10, 13, 96, 226 💬
96NO intervention- observational SUB-study----1件: 226 💬
97Normal saline----20件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
98Normal saline instillation----1件: 226 💬
99Nortriptyline1件: Nortriptyline2件: Nortriptyline hydrochloride ,
Nortriptyline 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 226 💬
100Omalizumab1件: Omalizumab1件: Omalizumab 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
101Onabotulinum toxin A----1件: 226 💬
102Onabotulinumtoxin A----2件: 51, 226 💬
103ONO-1110----1件: 226 💬
104Operative cystoscopy----1件: 226 💬
105OXN 10/5 MG PR----1件: 226 💬
106OXN 20/10 MG PR----1件: 226 💬
107OXN 5/2.5 MG PR----1件: 226 💬
108Oxycodone hydrochloride1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298 💬
109Oxycodone naloxone prolonged release tablets1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
110Oxycodone/naloxone prolonged release T2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
111Oxycodone/naloxone prolonged release tablets 10/5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
112Oxycodone/naloxone prolonged release tablets 20/10 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
113Oxycodone/naloxone prolonged release tablets 5/2.5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
114Oxytocin1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬4件: 127, 168, 193, 226 💬
115Ozone1件: Ozone---4件: 49, 51, 70, 226 💬
116PD 0299685----1件: 226 💬
117PD 0299685 AT 15MG BID----1件: 226 💬
118PD 0299685 AT 30MG BID----1件: 226 💬
119PD-02996851件: PD-0299685---1件: 226 💬
120Pelvic floor physical therapy----1件: 226 💬
121Pentosan polysulfate sodium 100 MG1件: Pentosan polysulfate1件: Pentosan polysulfate sodium 💬 --1件: 226 💬
122PF-04383119----1件: 226 💬
123Platelet enriched plasma----1件: 226 💬
124Platelet-rich plasma----1件: 226 💬
125Prograf1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 222, 226 💬
126Propiverine hydrochloride1件: Propiverine2件: Propiverine hydrochloride ,
Propiverine 💬 		9件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		44件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
127PRP----2件: 90, 226 💬
128Rimegepant1件: Rimegepant2件: Rimegepant ,
Rimegepant sulfate 💬 		1件: CALCRL 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
129Rimso 50----1件: 226 💬
130RN624, RI624----1件: 226 💬
131Saline AS A nasal spray----1件: 226 💬
132Sandimmun----2件: 97, 226 💬
133Sandimmun neoral1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬4件: 54, 60, 97, 226 💬
134Sham cystoscopy procedure----1件: 226 💬
135SI-722----1件: 226 💬
136Sildenafil1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬14件: 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
137Sodium bicarbonate1件: Sodium bicarbonate1件: Sodium bicarbonate 💬 --3件: 97, 226, 299 💬
138Sodium chloride injection1件: Sodium chloride1件: Sodium chloride 💬 --1件: 226 💬
139Sodium hyaluronate1件: Hyaluronic acid2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--3件: 53, 97, 226 💬
140Suplatast tosilate1件: Suplatast1件: Suplatast tosilate 💬 --1件: 226 💬
141Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬31件: 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
142Tanezumab1件: Tanezumab1件: Tanezumab 💬 1件: NGFB 💬 9件: Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 226, 298 💬
143Targinact 10 MG/5 MG prolonged-release tablets----2件: 6, 226 💬
144Targinact 20MG/10 MG prolonged-release tablets----1件: 226 💬
145Targinact 5MG/2.5 MG prolonged-release tablets----1件: 226 💬
146Tramadol1件: Tramadol2件: Tramadol hydrochloride ,
Tramadol 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 226 💬
147Transvaginal botulinum toxin A (BTA) injection----1件: 226 💬
148Triamcinolone1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬6件: 46, 53, 90, 96, 226, 298 💬
149TTI-1612----1件: 226 💬
150Ubrogepant1件: Ubrogepant1件: Ubrogepant 💬 1件: CALCRL 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
151URG101----1件: 226 💬
152Urodynamic study----1件: 226 💬
153Usual urogynecologic care----1件: 226 💬
154V117957----1件: 226 💬
155Vaginal estrogen----1件: 226 💬
156VNX001----1件: 226 💬
157Water1件: Water1件: Water 💬 --25件: 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
158YM672----1件: 226 💬